Skip to main content Accessibility help
×
Home

Clinical impact of delaying initiation of radiotherapy in patients with breast cancer: stages 0, I and II, a retrospective observational study

  • Raquel Cobos Campos (a1), Antxon Apiñaniz Fernández de Larrinoa (a2), Arantza Sáez de Lafuente Moriñigo (a1), Naiara Parraza Diez (a1), Felipe Aizpuru Barandiaran (a1) (a3) (a4), Avelino Alia Ramos (a5) and Aurora Lasso Varela (a6)...

Abstract

Background

There is no consensus on how long the initiation of radiotherapy (RT) can be delayed after surgery without a negative impact on survival.

Materials and methods

We conducted a retrospective study of 278 patients with stage 0–II breast cancer, all of whom were treated with surgery and RT, with those at stages I–II also receiving chemotherapy. Patients were followed-up for 5 years after diagnosis to assess disease-free and overall survival.The independent variable was the delay in the initiation of RT, assessed by two criteria: time since the last treatment, considered acceptable if ≤6 weeks, and time since surgery, considered acceptable if ≤7 months, these cut-offs being used to categorise patients into two groups according to the length of delay.

Results

No statistically significant differences were observed in the probability of disease-free survival (p=0·412) or overall survival (p=0·890). The appearance of recurrence was 5–59 months, with an average of 38·50 (14·31).

Conclusions

Delaying the initiation of RT for more than 6 weeks after last treatment does not seem to have a negative impact on disease-free or overall survival.

Copyright

Corresponding author

Correspondence to: Aurora Lasso Varela, Oncology Radiotherapy Service, Cruces University Hospital, Cruces square, 12, 48903 Barakaldo, Vizkaya, Spain. Tel: 946006398. Fax: 945007413. E-mail: MARIAAURORA.LASSOVARELA@osakidetza.net

References

Hide All
1Poggi, M M, Danforth, D N, Sciuto, L Cet al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003; 98 (4): 697702.
2Mackillop, W J. Killing time: the consequences of delays in radiotherapy. Radiother Oncol 2007; 84: 14.
3Tubiana, M. Repopulation in human tumors, a biological background for fractionation in radiotherapy. Acta Oncol 1988; 27: 8388.
4Chen, Z, King, W, Pearcey, R, Kerba, M, Mackillop, W J. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol 2008; 87: 316.
5Huang, J, Barbera, L, Brouwers, M, Browman, G, William, J, Mackillop, W J. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003; 21: 555563.
6Olivotto, I A, Lesperance, M L, Truong, P Tet al. Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy. J Clin Oncol 2009; 27 (1): 1623.
7Punglia, R S, Saito, A M, Neville, B A, Earle, C C, Weeks, J C. Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis. BMJ 2010; 340: c845.
8Yock, T I, Taghian, A G, Kachnic, L A, Coen, J J, Assaad, S I, Powell, S N. The effect of delaying radiation therapy for systemic chemotherapy on local-regional control in breast cancer. Breast Cancer Res Treat 2004; 84: 161171.
9Benchalal, M, Boisselier, P, de Lafontan, Bet al. Influence of the delay between conservative surgery and radiation therapy on local relapse in node-positive breast tumor. Bull Cancer 2006; 93 (3): 303313.
10Hickey, B E, Francis, D P, Lehman, M. Sequencing of chemotherapy and radiotherapy for early breast cancer (review). Cochrane Database Syst Rev 2013; 30 (4): CD005212, doi: 10.1002/14651858.CD005212.pub3.
11Corradini, S, Niemoeller, O M, Niyazi, Met al. Timing of radiotherapy following breast-conserving surgery: outcome of 1393 patients at a single institution. Strahlenther Onkol 2014; 190: 352357.
12Hébert-Croteau, N, Freeman, C R, Latreille, J, Brisson, J. Delay in adjuvant radiation treatment and outcomes of breast cancer review. Breast Cancer Res Treat 2003; 74: 7794.
13Recht, A. Impact on outcome of delay in starting radiotherapy. J Clin Oncol 2004; 22: 13411342.
14Jack, R H, Davies, E A, Robinson, D, Sainsbury, R, Moller, H. Radiotherapy waiting times for women with breast cancer: a population-based cohort study. BMC Cancer 2007; 7: 71.
15Johnston, G M, MacGarvie, V L, Elliott, D, Dewar, R A, MacIntyre, M M, Nolan, M C. Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000. Clin Invest Med 2004; 27: 142156.
16Mackillop, W J, Fu, H, Quirt, C F, Dixon, P, Brundage, M, Zhou, Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 1994; 30: 221228.
17Tsoutsou, P G, Koukourakis, M I, Azria, D, Belkacemi, Y. Optimal timing for adjuvant radiation therapy in breast cancer: a comprehensive review and perspectives. Crit Rev Oncol Hematol 2009; 71: 102116.
18Mikeljevic, J S, Haward, R, Johnston, Cet al. Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservations surgery. Br J Cancer 2004; 90 (7): 13431348.
19Singletary, S E, Greene, F L, Breast Task Force. Revision of breast cancer staging: the 6th edition of the TNM Classification. Semin Surg Oncol 2003; 21 (1): 5359.
20Clarke, M, Collins, R, Darby, Set al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 20872106.
21Nixon, A J, Neuberg, D, Hayes, D Fet al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994; 12 (5): 888894.
22Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365 (9472): 16871717.
23Mass, H, Engle, B, Trams, G. Steroid hormone receptors in human breast cancer and the clinical significance. J Steroid Biochem 1975; 6: 743749.
24Rosen, P R, Groshen, S, Saigo, P E, Kinne, D W, Hellman, S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989; 7 (3): 355366.
25Ciatto, S, Biggeri, A, Rosselli Del Turco, M, Bartoli, D, Iossa, A. Risk of breastcancer subsequent to proven gross cystic disease. Eur J Cancer 1990; 26: 555557.
26Fuentes, M J, Piedrafita, E, Isern, Jet al. Recidivas locorregionales tras el tratamiento conservador del cáncer de mama en estadios I y II. Med Clin (Barc) 2002; 118 (5): 161165.
27Gegúndez, C, Monjero, I, Martín, M Vet al. Enfermedad residual después de cirugía conservadora por cáncer de mama. Prog Obstet Ginecol 2009; 52 (8): 437442.
28Veronesi, U, Salvadori, B, Luini, Aet al. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg 1990; 211 (3): 250259.
29Neff, P, Bear, H, Pierce, C. Long-term results of breast conservation therapy for breast cancer. Ann Surg 1996; 223 (6): 709717.
30Agarwal, S, Pappas, L, Neumayer, L, Kokeny, K, Agarwal, J. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg 2014; 149 (3): 267274.
31Klein, C A. Parallel progression of primary tumors and metastases. Nat Rev Cancer 2009; 9: 302312.
32Bouche, G, Ingrand, I, Mathoulin-Pelissier, S, Ingrand, P, Breton-Callu, C, Migeot, V. Determinants of variability in waiting times for radiotherapy in the treatment of breast cancer. Ratiother Oncol 2010; 97: 541547.

Keywords

Clinical impact of delaying initiation of radiotherapy in patients with breast cancer: stages 0, I and II, a retrospective observational study

  • Raquel Cobos Campos (a1), Antxon Apiñaniz Fernández de Larrinoa (a2), Arantza Sáez de Lafuente Moriñigo (a1), Naiara Parraza Diez (a1), Felipe Aizpuru Barandiaran (a1) (a3) (a4), Avelino Alia Ramos (a5) and Aurora Lasso Varela (a6)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed